drugset
drugset / Trial / NCT01539265

A Dose-finding Study of Silodosin in Patients With Urinary Calculi

NCT01539265 ↗

Phase 2 Completed 300 enrolled Kissei Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and the safety of silodosin in urinary calculi patients.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Silodosin Unknown — —

Indications

urolithiasis